225 related articles for article (PubMed ID: 24507660)
1. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression.
Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL
BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660
[TBL] [Abstract][Full Text] [Related]
2. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma.
Yang LY; Lu WQ; Huang GW; Wang W
BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286
[TBL] [Abstract][Full Text] [Related]
3. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation].
Wang Y; Zhang XH; Guo P; Yan LN; He D
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and comparison of microvessel density using the markers CD34 and CD105 in regenerative nodules, dysplastic nodules and hepatocellular carcinoma.
Segatelli V; de Oliveira EC; Boin IF; Ataide EC; Escanhoela CA
Hepatol Int; 2014 Apr; 8(2):260-5. PubMed ID: 26202507
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density assessment in benign and malignant endometrial changes.
Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K
J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF.
Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y
Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver.
Ho JW; Poon RT; Sun CK; Xue WC; Fan ST
World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions.
Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S
Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986
[TBL] [Abstract][Full Text] [Related]
9. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas.
Barresi V; Cerasoli S; Vitarelli E; Tuccari G
Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108
[TBL] [Abstract][Full Text] [Related]
10. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of microvessel density quantified through the immunohistochemistry expression of CD34 and CD105 in rectal cancer.
Goldiş DS; Sferdian MF; Tarţă C; Fulger LO; Totolici BD; Neamţu C
Rom J Morphol Embryol; 2015; 56(2):419-24. PubMed ID: 26193208
[TBL] [Abstract][Full Text] [Related]
12. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of microvessel density in patients with renal cell carcinoma: a meta-analysis.
Cheng SH; Liu JM; Liu QY; Luo DY; Liao BH; Li H; Wang KJ
Int J Clin Exp Pathol; 2014; 7(9):5855-63. PubMed ID: 25337227
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of CD105-assessed microvessel density in laryngeal carcinoma.
Zvrko E; Mikic A; Vuckovic L; Djukic V; Knezevic M
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):478-83. PubMed ID: 19786216
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
Yao Y; Kubota T; Takeuchi H; Sato K
Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of microvessel density (MVD) in laryngeal squamous cell carcinoma].
Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
Przegl Lek; 2012; 69(10):726-30. PubMed ID: 23421020
[TBL] [Abstract][Full Text] [Related]
18. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome.
Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P
Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in superficial esophageal squamous cell carcinoma: assessment of microvessel density based on immunostaining for CD34 and CD105.
Kumagai Y; Sobajima J; Higashi M; Ishiguro T; Fukuchi M; Ishibashi K; Baba H; Mochiki E; Yakabi K; Kawano T; Tamaru J; Ishida H
Jpn J Clin Oncol; 2014 Jun; 44(6):526-33. PubMed ID: 24748644
[TBL] [Abstract][Full Text] [Related]
20. Morphometric evaluation of vascularization of hepatic focal nodular hyperplasia.
Shchyogolev AI; Tumanova UN; Dubova EA
Bull Exp Biol Med; 2013 Dec; 156(2):266-70. PubMed ID: 24319765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
